Search





Search





Markets
/
Stocks
/
nasdaq-vrxa
/

Veraxa Biotech AG Ord Shs

VRXA

Add to Watchlist

2.390USD

+0.090+3.91%

Market hours （ET）Quotes delayed by 15 min

75.58MMarket Cap

--P/E TTM

Veraxa Biotech AG Ord Shs

2.390

+0.090+3.91%

Earnings Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Earnings Income Statement Balance Sheet Cash Flow Statement

You can find the annual or quarterly income statement of Veraxa Biotech AG Ord Shs here for insights into the performance and operational efficiency of Veraxa Biotech AG Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

Operating expenses

--2.19M

Operating profit

---2.19M

Net non-operating interest income (expenses)

Non-operating interest income

--431.00

Gains from sale of securities

--2.37M

Income before tax

--180.50K

Income after tax

--180.50K

Net income from continuous operations

--180.50K

Net income attributable to controlling interests

--180.50K

Net income attributable to common shareholders

--180.50K

Basic earnings per share

--0.01

Diluted earnings per share

--0.01

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

